{"gene":"ELFN1","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2012,"finding":"ELFN1 protein is selectively expressed by O-LM interneurons and, when expressed postsynaptically, regulates presynaptic release probability to direct the formation of highly facilitating pyramidal-O-LM synapses with low initial release probability.","method":"Selective expression analysis combined with in vivo electrophysiology and loss-of-function experiments in hippocampal slices","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — foundational discovery, replicated and extended by multiple subsequent independent labs","pmids":["23042292"],"is_preprint":false},{"year":2013,"finding":"Elfn1 is expressed in distinct subsets of interneurons in hippocampus and cortex, and Elfn1 mutant mice exhibit seizures, hyperactivity, and motor abnormalities; Elfn1 protein localizes to axons of excitatory neurons in the habenula and long-range GABAergic neurons of the globus pallidus, suggesting presynaptic or axonal roles in addition to postsynaptic ones.","method":"β-galactosidase reporter knock-in expression mapping, behavioral analysis (open-field, amphetamine challenge), immunohistochemistry in Elfn1 knockout mice","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined behavioral phenotype and direct localization, single lab","pmids":["24312227"],"is_preprint":false},{"year":2014,"finding":"ELFN1 interacts in trans with presynaptic mGluR7, recruiting it to synaptic sites on somatostatin-containing interneurons (SOM-INs) in hippocampal CA1 stratum oriens and dentate gyrus hilus; loss of Elfn1 causes deficits in mGluR7 recruitment, impairs presynaptic plasticity at these synapses, and results in hyperactivity and sensory-triggered epileptic seizures in mice. Damaging missense mutations of human ELFN1 clustered in the C-terminal region required for mGluR7 recruitment were found in patients with epilepsy and ADHD.","method":"Elfn1 knockout mice, co-immunoprecipitation, immunofluorescence localization, ex vivo electrophysiology, human patient mutation analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction validated, KO with defined synaptic and behavioral phenotype, replicated across labs","pmids":["25047565"],"is_preprint":false},{"year":2018,"finding":"ELFN1 binds selectively to all group III mGluRs (mGluR4, mGluR6, mGluR7, mGluR8) but not other mGluR subtypes via two distinct sites on its ectodomain; ELFN1 acts as a transsynaptic allosteric modulator of group III mGluR activity, suppressing cAMP accumulation by altering both agonist-induced and constitutive receptor activity, and alters the ability of mGluRs to activate G proteins.","method":"Site-directed mutagenesis of ELFN1 ectodomain, transcellular signaling reconstitution assay in HEK293 cells, BRET-based real-time kinetic G protein activation assays, cAMP accumulation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — reconstitution assay with mutagenesis, multiple orthogonal methods in single study","pmids":["29686062"],"is_preprint":false},{"year":2019,"finding":"The transsynaptic Elfn1/mGluR7 interaction constitutively activates mGluR7 in a glutamate-independent manner through presynaptic clustering, tonically suppressing initial release probability at pyramidal→SOM interneuron synapses. Additionally, Elfn1 recruits presynaptic GluK2-containing kainate receptors (GluK2-KARs) as a second component of facilitating synapses, with layer-specific differences: L2/3 SOM neurons show GluK2-KAR activity at baseline while L5 SOM neurons do not, but can be induced by calmodulin activation.","method":"Whole-cell patch-clamp electrophysiology in cortical slices, pharmacological dissection (mGluR7 antagonists, kainate receptor antagonists), mouse conditional knockout","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — clean loss-of-function with defined synaptic phenotype, pharmacological dissection, multiple orthogonal approaches","pmids":["30940718"],"is_preprint":false},{"year":2020,"finding":"N-glycosylation of mGluR7 at four asparagine residues is essential for its forward trafficking and surface expression; deglycosylated mGluR7 is retained in the ER and degraded via the autophagolysosomal pathway. N-glycosylation also promotes mGluR7 interaction with ELFN1, enabling proper localization and stable surface expression of mGluR7 at the presynaptic active zone.","method":"Site-directed mutagenesis of N-glycosylation sites, co-immunoprecipitation, immunofluorescence in heterologous cells and cultured neurons, pharmacological inhibition of glycosylation","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis plus multiple biochemical methods, single lab","pmids":["32931036"],"is_preprint":false},{"year":2024,"finding":"The intracellular domain of ELFN1 controls membrane trafficking and postsynaptic localization, with a ~30 amino acid juxtamembranous region required for membrane targeting. ELFN1 exists as an obligate homodimer prior to membrane trafficking, with homodimerization mediated by the extracellular leucine-rich repeat (LRR) domain rather than the intracellular region. A single membrane-targeting motif in one protomer is sufficient for trafficking of the ELFN1 homodimer. ELFN2 (closest homolog) exhibits similar properties and can heterodimerize with ELFN1.","method":"Domain deletion mutagenesis, subcellular fractionation, co-immunoprecipitation, live-cell imaging, size-exclusion chromatography","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods with mutagenesis, single lab","pmids":["39675706"],"is_preprint":false},{"year":2024,"finding":"CSNB-associated missense mutations in the extracellular ligand-binding domain of mGluR6 cause a Golgi bypass trafficking defect, preventing complex N-glycosylation and abolishing ELFN1 binding; these mutants are mislocalized in bipolar cells, revealing that Golgi trafficking and proper N-glycosylation of the mGluR6 extracellular domain are required for ELFN1 interaction and synaptic localization.","method":"Biochemical glycosylation assays, in vitro binding assays, immunofluorescence localization in bipolar cells, analysis of patient-derived missense mutations","journal":"Life science alliance","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical and cell biology methods with disease mutations, single lab","pmids":["39681475"],"is_preprint":false},{"year":2024,"finding":"ELFN1 is associated with extracellular matrix function: primary skin fibroblasts from patients carrying a frameshift mutation in the ELFN1 signal peptide show severely reduced ELFN1 expression and dramatically altered fibroblast morphology, growth, proliferation, and motility, suggesting ELFN1 is involved in cell-ECM attachment.","method":"Primary fibroblast culture from patient skin biopsies, in vitro ECM and decellularized ECM (DEM) models, comparative morphological and functional characterization","journal":"Life sciences","confidence":"Low","confidence_rationale":"Tier 3 — single lab, indirect loss-of-function via patient mutation, no direct molecular mechanism established","pmids":["38986898"],"is_preprint":false},{"year":2025,"finding":"Biallelic ELFN1 variants (frameshift and in-frame deletions) disrupt ELFN1 protein trafficking to the cell surface, resulting in loss of function; functional modeling in mice and zebrafish demonstrates that Elfn1 loss causes motor activity abnormalities and seizures.","method":"Patient variant characterization, cell surface trafficking assays, mouse and zebrafish loss-of-function models with behavioral/seizure phenotyping","journal":"Genetics in medicine","confidence":"Medium","confidence_rationale":"Tier 2 — trafficking assay with multiple patient variants, in vivo model validation","pmids":["40576023"],"is_preprint":false},{"year":2025,"finding":"The LRR and LRR C-terminal cap (LRRCT) regions of the ELFN1 extracellular domain are necessary and sufficient for binding to all Group III mGluRs including mGluR6. Deletion of the LRRCT domain abolishes trafficking of ELFN1 to rod photoreceptor axon terminal spherules. In mGluR6-null mice, presynaptic ELFN1 loses precise colocalization with synapses, and this defect is rescued by expressing mGluR6-EGFP in ON-bipolar cells, demonstrating bidirectional mutual regulation of presynaptic ELFN1 and postsynaptic mGluR6 enrichment.","method":"In vitro binding assays with ELFN1 domain deletion constructs, immunofluorescence in mGluR6 knockout and rescue mice, expression of ELFN1-flag domain deletion constructs in rods","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — domain mapping with binding assay plus in vivo rescue, single lab","pmids":["40930976"],"is_preprint":false}],"current_model":"ELFN1 is a postsynaptic transmembrane cell adhesion molecule expressed in somatostatin/O-LM interneurons that acts as a transsynaptic allosteric modulator of all group III metabotropic glutamate receptors (mGluR4/6/7/8) via its extracellular LRR-LRRCT domain, constitutively activating presynaptic mGluR7 in a glutamate-independent manner to suppress initial release probability and generate facilitating synapses; it exists as an obligate homodimer whose membrane trafficking is controlled by a juxtamembranous intracellular motif, and loss of ELFN1 function in mice and humans causes seizures, hyperactivity, and neurodevelopmental encephalopathy."},"narrative":{"teleology":[{"year":2012,"claim":"Establishing that ELFN1 is a synapse-type-specific organizer: the fundamental question of what molecular mechanism generates facilitating synapses onto O-LM interneurons was answered by showing that postsynaptic ELFN1 expression controls presynaptic release probability.","evidence":"Expression mapping combined with loss-of-function electrophysiology in hippocampal slices","pmids":["23042292"],"confidence":"High","gaps":["Trans-synaptic binding partner not yet identified","Mechanism of presynaptic modulation unknown","Broader expression outside O-LM interneurons unexplored"]},{"year":2014,"claim":"Identifying the trans-synaptic partner: the unknown presynaptic target of ELFN1 was revealed to be mGluR7, with ELFN1 recruiting mGluR7 to specific synaptic sites; human epilepsy-associated mutations in the ELFN1 C-terminal region disrupted this interaction, linking ELFN1 dysfunction to neurological disease.","evidence":"Co-immunoprecipitation, immunofluorescence, Elfn1 knockout electrophysiology, human patient mutation analysis","pmids":["25047565"],"confidence":"High","gaps":["Whether ELFN1 interacts with other mGluR subtypes unknown","Mechanism of allosteric modulation not established","Whether ELFN1 acts only postsynaptically or also presynaptically unresolved"]},{"year":2018,"claim":"Defining the allosteric mechanism: it was unknown how ELFN1 modulates mGluR function; reconstitution showed ELFN1 binds all group III mGluRs (but not other subtypes) via two ectodomain sites and acts as a transsynaptic allosteric modulator that alters both agonist-induced and constitutive G protein coupling.","evidence":"Site-directed mutagenesis, transcellular signaling reconstitution in HEK293 cells, BRET-based G protein activation and cAMP assays","pmids":["29686062"],"confidence":"High","gaps":["Structural basis of allosteric modulation unresolved","In vivo relevance for mGluR4/6/8 interactions not tested","Whether two binding sites have distinct functional roles unclear"]},{"year":2019,"claim":"Demonstrating glutamate-independent constitutive activation: it was unclear whether ELFN1/mGluR7 signaling required glutamate; electrophysiology showed ELFN1 constitutively activates mGluR7 through presynaptic clustering, tonically suppressing release probability, and additionally recruits GluK2-KARs as a second facilitating mechanism with layer-specific differences.","evidence":"Whole-cell patch-clamp in cortical slices with pharmacological dissection and conditional knockout","pmids":["30940718"],"confidence":"High","gaps":["Molecular basis of GluK2-KAR recruitment by ELFN1 unknown","How calmodulin regulates layer-specific differences not defined","Whether ELFN2 has similar dual-receptor organizing capacity untested"]},{"year":2020,"claim":"Establishing glycosylation dependence of the interaction: it was unknown what post-translational modifications regulate the ELFN1-mGluR7 complex; N-glycosylation of mGluR7 proved essential for both surface trafficking and ELFN1 binding.","evidence":"N-glycosylation site mutagenesis, co-immunoprecipitation, immunofluorescence in heterologous cells and neurons","pmids":["32931036"],"confidence":"Medium","gaps":["Whether ELFN1 itself requires glycosylation for function not addressed","In vivo validation of glycosylation mutants lacking","Stoichiometry of the glycosylated mGluR7-ELFN1 complex unknown"]},{"year":2024,"claim":"Resolving quaternary structure and trafficking: the oligomeric state and trafficking determinants of ELFN1 were unknown; ELFN1 was shown to be an obligate LRR-mediated homodimer, with a ~30 amino acid juxtamembranous intracellular motif controlling membrane targeting, and a single motif in one protomer sufficient for dimer trafficking.","evidence":"Domain deletion mutagenesis, size-exclusion chromatography, co-immunoprecipitation, live-cell imaging","pmids":["39675706"],"confidence":"Medium","gaps":["Structure of the ELFN1 homodimer not determined at atomic resolution","Whether homodimerization is required for mGluR binding not tested","Identity of the juxtamembranous motif-binding trafficking machinery unknown"]},{"year":2025,"claim":"Mapping the minimal mGluR-binding domain and demonstrating bidirectional synaptic stabilization: the LRR-LRRCT region was shown to be necessary and sufficient for all group III mGluR binding, LRRCT deletion abolished presynaptic trafficking to rod spherules, and mGluR6 expression in postsynaptic bipolar cells was required to stabilize presynaptic ELFN1, establishing mutual transsynaptic enrichment.","evidence":"ELFN1 domain deletion binding assays, immunofluorescence in mGluR6 knockout and rescue mice, rod-specific transgene expression","pmids":["40930976"],"confidence":"Medium","gaps":["Structural basis of LRR-LRRCT interaction with mGluR Venus flytrap domain unresolved","Whether bidirectional stabilization occurs at all ELFN1-expressing synapses unknown","Functional consequences of losing presynaptic ELFN1 in retina not measured electrophysiologically"]},{"year":2025,"claim":"Establishing ELFN1 as a Mendelian disease gene: biallelic loss-of-function variants were shown to disrupt ELFN1 surface trafficking and cause a neurodevelopmental encephalopathy with seizures and motor abnormalities, validated across human patients and animal models.","evidence":"Patient variant characterization, cell surface trafficking assays, mouse and zebrafish loss-of-function behavioral phenotyping","pmids":["40576023"],"confidence":"Medium","gaps":["Genotype-phenotype correlations for different variant types not established","Whether heterozygous carriers have intermediate phenotypes unclear","Circuit-level mechanisms linking ELFN1 loss to seizure generation not defined"]},{"year":null,"claim":"Key unresolved questions include the atomic structure of the ELFN1 homodimer-mGluR complex, the identity of intracellular trafficking machinery recognizing the juxtamembranous motif, the molecular basis of GluK2-KAR recruitment, and whether ELFN1 has non-neuronal functions related to its effects on fibroblast morphology.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of the ELFN1-mGluR transsynaptic complex exists","Intracellular signaling partners and scaffolding interactions of ELFN1 C-terminal domain undefined","Potential ECM/fibroblast role observed only in a single low-confidence study"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,4]},{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,2,10]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[6,9]},{"term_id":"GO:0043226","term_label":"organelle","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,2,4]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4]}],"complexes":[],"partners":["GRM7","GRM4","GRM6","GRM8","GRIK2","ELFN2"],"other_free_text":[]},"mechanistic_narrative":"ELFN1 is a postsynaptic leucine-rich repeat transmembrane protein that functions as a transsynaptic organizer of facilitating synapses by allosterically modulating presynaptic group III metabotropic glutamate receptors. Selectively expressed in somatostatin-positive interneurons, ELFN1 binds in trans to mGluR4, mGluR6, mGluR7, and mGluR8 via its extracellular LRR-LRRCT domain, constitutively activating mGluR7 in a glutamate-independent manner to suppress initial release probability and recruit GluK2-containing kainate receptors as a second facilitating component [PMID:23042292, PMID:29686062, PMID:30940718]. ELFN1 exists as an obligate homodimer mediated by its LRR domain, with membrane trafficking controlled by a juxtamembranous intracellular motif, and proper N-glycosylation of its mGluR partners is required for stable ELFN1 binding and synaptic localization [PMID:39675706, PMID:32931036, PMID:40930976]. Biallelic loss-of-function variants in ELFN1 cause a neurodevelopmental syndrome with seizures, hyperactivity, and motor abnormalities in humans and animal models [PMID:25047565, PMID:40576023]."},"prefetch_data":{"uniprot":{"accession":"P0C7U0","full_name":"Protein ELFN1","aliases":["Extracellular leucine-rich repeat and fibronectin type-III domain-containing protein 1","Protein phosphatase 1 regulatory subunit 28"],"length_aa":828,"mass_kda":90.5,"function":"Postsynaptic protein that regulates circuit dynamics in the central nervous system by modulating the temporal dynamics of interneuron recruitment. Specifically present in excitatory synapses onto oriens-lacunosum molecular (OLM) interneurons and acts as a regulator of presynaptic release probability to direct the formation of highly facilitating pyramidal-OLM synapses (By similarity). Inhibits phosphatase activity of protein phosphatase 1 (PP1) complexes","subcellular_location":"Membrane; Cell projection, dendrite; Cell projection, axon","url":"https://www.uniprot.org/uniprotkb/P0C7U0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ELFN1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ELFN1","total_profiled":1310},"omim":[{"mim_id":"621344","title":"DURSUN-OZGUL NEURODEVELOPMENTAL SYNDROME; DONDS","url":"https://www.omim.org/entry/621344"},{"mim_id":"614964","title":"EXTRACELLULAR LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1; ELFN1","url":"https://www.omim.org/entry/614964"},{"mim_id":"308350","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1; DEE1","url":"https://www.omim.org/entry/308350"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cell Junctions","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"liver","ntpm":13.2}],"url":"https://www.proteinatlas.org/search/ELFN1"},"hgnc":{"alias_symbol":[],"prev_symbol":["PPP1R28"]},"alphafold":{"accession":"P0C7U0","domains":[{"cath_id":"3.80.10.10","chopping":"28-191","consensus_level":"high","plddt":91.6693,"start":28,"end":191},{"cath_id":"2.60.40.10","chopping":"319-400","consensus_level":"high","plddt":85.2883,"start":319,"end":400}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P0C7U0","model_url":"https://alphafold.ebi.ac.uk/files/AF-P0C7U0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P0C7U0-F1-predicted_aligned_error_v6.png","plddt_mean":61.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ELFN1","jax_strain_url":"https://www.jax.org/strain/search?query=ELFN1"},"sequence":{"accession":"P0C7U0","fasta_url":"https://rest.uniprot.org/uniprotkb/P0C7U0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P0C7U0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P0C7U0"}},"corpus_meta":[{"pmid":"35351858","id":"PMC_35351858","title":"Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer.","date":"2022","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35351858","citation_count":139,"is_preprint":false},{"pmid":"23042292","id":"PMC_23042292","title":"Elfn1 regulates target-specific release probability at CA1-interneuron synapses.","date":"2012","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/23042292","citation_count":126,"is_preprint":false},{"pmid":"25047565","id":"PMC_25047565","title":"Elfn1 recruits presynaptic mGluR7 in trans and its loss results in seizures.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25047565","citation_count":98,"is_preprint":false},{"pmid":"29686062","id":"PMC_29686062","title":"Synaptic adhesion protein ELFN1 is a selective allosteric modulator of group III metabotropic glutamate receptors in trans.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29686062","citation_count":66,"is_preprint":false},{"pmid":"30940718","id":"PMC_30940718","title":"Elfn1-Induced Constitutive Activation of mGluR7 Determines Frequency-Dependent Recruitment of Somatostatin Interneurons.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30940718","citation_count":53,"is_preprint":false},{"pmid":"32229685","id":"PMC_32229685","title":"LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p.","date":"2020","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32229685","citation_count":44,"is_preprint":false},{"pmid":"31929141","id":"PMC_31929141","title":"ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644/TRIM44 axis.","date":"2020","source":"Cancer biomarkers : section A of Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/31929141","citation_count":41,"is_preprint":false},{"pmid":"32779991","id":"PMC_32779991","title":"ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer.","date":"2020","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/32779991","citation_count":38,"is_preprint":false},{"pmid":"24312227","id":"PMC_24312227","title":"Mutation of Elfn1 in mice causes seizures and hyperactivity.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24312227","citation_count":32,"is_preprint":false},{"pmid":"31814902","id":"PMC_31814902","title":"Extracellular vesicles from human umbilical cord mesenchymal stem cells treated with siRNA against ELFN1-AS1 suppress colon adenocarcinoma proliferation and migration.","date":"2019","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/31814902","citation_count":29,"is_preprint":false},{"pmid":"35785218","id":"PMC_35785218","title":"Osteosarcoma Cell-Derived Exosomal ELFN1-AS1 Mediates Macrophage M2 Polarization via Sponging miR-138-5p and miR-1291 to Promote the Tumorgenesis of Osteosarcoma.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35785218","citation_count":28,"is_preprint":false},{"pmid":"24707484","id":"PMC_24707484","title":"ELFN1-AS1: a novel primate gene with possible microRNA function expressed predominantly in human tumors.","date":"2014","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/24707484","citation_count":22,"is_preprint":false},{"pmid":"32931036","id":"PMC_32931036","title":"N-linked glycosylation of the mGlu7 receptor regulates the forward trafficking and transsynaptic interaction with Elfn1.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32931036","citation_count":21,"is_preprint":false},{"pmid":"33634016","id":"PMC_33634016","title":"Long Non-Coding RNA ELFN1-AS1 Promoted Colon Cancer Cell Growth and Migration via the miR-191-5p/Special AT-Rich Sequence-Binding Protein 1 Axis.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33634016","citation_count":20,"is_preprint":false},{"pmid":"33574704","id":"PMC_33574704","title":"LncRNA ELFN1-AS1 Promotes Retinoblastoma Growth and Invasion via Regulating miR-4270/SBK1 Axis.","date":"2021","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33574704","citation_count":19,"is_preprint":false},{"pmid":"37147528","id":"PMC_37147528","title":"ELFN1-AS1 promotes GDF15-mediated immune escape of colorectal cancer from NK cells by facilitating GCN5 and SND1 association.","date":"2023","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37147528","citation_count":19,"is_preprint":false},{"pmid":"36786074","id":"PMC_36786074","title":"lncRNA ELFN1-AS1 promotes proliferation, migration and invasion and suppresses apoptosis in colorectal cancer cells by enhancing G6PD activity.","date":"2023","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/36786074","citation_count":16,"is_preprint":false},{"pmid":"35652045","id":"PMC_35652045","title":"Hypoxia-Induced Upregulation of lncRNA ELFN1-AS1 Promotes Colon Cancer Growth and Metastasis Through Targeting TRIM14 via Sponging miR-191-5p.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35652045","citation_count":16,"is_preprint":false},{"pmid":"34164511","id":"PMC_34164511","title":"Long non-coding RNA ELFN1-AS1 in the pathogenesis of pancreatic cancer.","date":"2021","source":"Annals of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34164511","citation_count":14,"is_preprint":false},{"pmid":"35857351","id":"PMC_35857351","title":"MYC-Induced Upregulation of Lncrna ELFN1-AS1 Contributes to Tumor Growth in Colorectal Cancer via Epigenetically Silencing TPM1.","date":"2022","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/35857351","citation_count":13,"is_preprint":false},{"pmid":"34337713","id":"PMC_34337713","title":"A long non-coding RNA, ELFN1-AS1, sponges miR-1250 to upregulate MTA1 to promote cell proliferation, migration and invasion, and induce apoptosis in colorectal cancer.","date":"2021","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34337713","citation_count":12,"is_preprint":false},{"pmid":"36876422","id":"PMC_36876422","title":"lncRNA ELFN1-AS1 upregulates TRIM29 by suppressing miR-211-3p to promote gastric cancer progression.","date":"2023","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/36876422","citation_count":11,"is_preprint":false},{"pmid":"34509675","id":"PMC_34509675","title":"Biallelic mutations in ELFN1 gene associated with developmental and epileptic encephalopathy and joint laxity.","date":"2021","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34509675","citation_count":10,"is_preprint":false},{"pmid":"35451560","id":"PMC_35451560","title":"Long non-coding RNA ELFN1-AS1-mediated ZBTB16 inhibition augments the progression of gastric cancer by activating the PI3K/AKT axis.","date":"2022","source":"The Kaohsiung journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35451560","citation_count":9,"is_preprint":false},{"pmid":"38478184","id":"PMC_38478184","title":"Role of long non-coding RNA ELFN1-AS1 in carcinogenesis.","date":"2024","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38478184","citation_count":6,"is_preprint":false},{"pmid":"36561847","id":"PMC_36561847","title":"lncRNA ELFN1-AS1 enhances the progression of colon cancer by targeting miR-4270 to upregulate AURKB.","date":"2022","source":"Open medicine (Warsaw, Poland)","url":"https://pubmed.ncbi.nlm.nih.gov/36561847","citation_count":5,"is_preprint":false},{"pmid":"39675706","id":"PMC_39675706","title":"Distinct autoregulatory roles of ELFN1 intracellular and extracellular domains on membrane trafficking, synaptic localization, and dimerization.","date":"2024","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39675706","citation_count":4,"is_preprint":false},{"pmid":"39681475","id":"PMC_39681475","title":"Defective glycosylation and ELFN1 binding of mGluR6 congenital stationary night blindness mutants.","date":"2024","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/39681475","citation_count":4,"is_preprint":false},{"pmid":"38037859","id":"PMC_38037859","title":"m6A-related lncRNAs as potential biomarkers and the lncRNA ELFN1-AS1/miR-182-5p/BCL-2 regulatory axis in diffuse large B-cell lymphoma.","date":"2023","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38037859","citation_count":4,"is_preprint":false},{"pmid":"39528458","id":"PMC_39528458","title":"The long noncoding RNA ELFN1-AS1 promotes gastric cancer growth and metastasis by interacting with TAOK1 to inhibit the Hippo signaling pathway.","date":"2024","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/39528458","citation_count":4,"is_preprint":false},{"pmid":"38986898","id":"PMC_38986898","title":"ELFN1 is a new extracellular matrix (ECM)-associated protein.","date":"2024","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38986898","citation_count":2,"is_preprint":false},{"pmid":"39757210","id":"PMC_39757210","title":"The expression of the lncRNAs USP30-AS1, ELFN1-AS1, GAS8-AS1, and SNHG11 in breast cancer samples from Iranian patients from 2014 to 2019: a cross-sectional study.","date":"2025","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/39757210","citation_count":2,"is_preprint":false},{"pmid":"40576023","id":"PMC_40576023","title":"ELFN1 deficiency: The mechanistic basis and phenotypic spectrum of a neurodevelopmental disorder with epilepsy.","date":"2025","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40576023","citation_count":1,"is_preprint":false},{"pmid":"38074639","id":"PMC_38074639","title":"Retraction: Long non-coding RNA ELFN1-AS1 promoted colon cancer cell growth and migration via the miR-191-5p/special AT-rich sequence-binding protein 1 axis.","date":"2023","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38074639","citation_count":1,"is_preprint":false},{"pmid":"40930976","id":"PMC_40930976","title":"Trans-synaptic Interaction with mGluR6 Contributes to ELFN1 Presynaptic Enrichment in Rod Photoreceptors.","date":"2025","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/40930976","citation_count":0,"is_preprint":false},{"pmid":"40689847","id":"PMC_40689847","title":"Profiling the Impact of mGlu7/Elfn1 Protein Interactions on the Pharmacology of mGlu7 Allosteric Modulators.","date":"2025","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/40689847","citation_count":0,"is_preprint":false},{"pmid":"41535615","id":"PMC_41535615","title":"LncRNA ELFN1-AS1 maintains the stemness of colorectal cancer by preventing ubiquitinated degradation of the hnRNPA1 protein.","date":"2026","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/41535615","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.09.23.24314219","title":"Digital phenotyping from wearables using AI characterizes psychiatric disorders and identifies genetic associations","date":"2024-09-24","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.23.24314219","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19706,"output_tokens":3027,"usd":0.052262},"stage2":{"model":"claude-opus-4-6","input_tokens":6358,"output_tokens":2567,"usd":0.143948},"total_usd":0.19621,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"ELFN1 protein is selectively expressed by O-LM interneurons and, when expressed postsynaptically, regulates presynaptic release probability to direct the formation of highly facilitating pyramidal-O-LM synapses with low initial release probability.\",\n      \"method\": \"Selective expression analysis combined with in vivo electrophysiology and loss-of-function experiments in hippocampal slices\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational discovery, replicated and extended by multiple subsequent independent labs\",\n      \"pmids\": [\"23042292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Elfn1 is expressed in distinct subsets of interneurons in hippocampus and cortex, and Elfn1 mutant mice exhibit seizures, hyperactivity, and motor abnormalities; Elfn1 protein localizes to axons of excitatory neurons in the habenula and long-range GABAergic neurons of the globus pallidus, suggesting presynaptic or axonal roles in addition to postsynaptic ones.\",\n      \"method\": \"β-galactosidase reporter knock-in expression mapping, behavioral analysis (open-field, amphetamine challenge), immunohistochemistry in Elfn1 knockout mice\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined behavioral phenotype and direct localization, single lab\",\n      \"pmids\": [\"24312227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ELFN1 interacts in trans with presynaptic mGluR7, recruiting it to synaptic sites on somatostatin-containing interneurons (SOM-INs) in hippocampal CA1 stratum oriens and dentate gyrus hilus; loss of Elfn1 causes deficits in mGluR7 recruitment, impairs presynaptic plasticity at these synapses, and results in hyperactivity and sensory-triggered epileptic seizures in mice. Damaging missense mutations of human ELFN1 clustered in the C-terminal region required for mGluR7 recruitment were found in patients with epilepsy and ADHD.\",\n      \"method\": \"Elfn1 knockout mice, co-immunoprecipitation, immunofluorescence localization, ex vivo electrophysiology, human patient mutation analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction validated, KO with defined synaptic and behavioral phenotype, replicated across labs\",\n      \"pmids\": [\"25047565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ELFN1 binds selectively to all group III mGluRs (mGluR4, mGluR6, mGluR7, mGluR8) but not other mGluR subtypes via two distinct sites on its ectodomain; ELFN1 acts as a transsynaptic allosteric modulator of group III mGluR activity, suppressing cAMP accumulation by altering both agonist-induced and constitutive receptor activity, and alters the ability of mGluRs to activate G proteins.\",\n      \"method\": \"Site-directed mutagenesis of ELFN1 ectodomain, transcellular signaling reconstitution assay in HEK293 cells, BRET-based real-time kinetic G protein activation assays, cAMP accumulation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution assay with mutagenesis, multiple orthogonal methods in single study\",\n      \"pmids\": [\"29686062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The transsynaptic Elfn1/mGluR7 interaction constitutively activates mGluR7 in a glutamate-independent manner through presynaptic clustering, tonically suppressing initial release probability at pyramidal→SOM interneuron synapses. Additionally, Elfn1 recruits presynaptic GluK2-containing kainate receptors (GluK2-KARs) as a second component of facilitating synapses, with layer-specific differences: L2/3 SOM neurons show GluK2-KAR activity at baseline while L5 SOM neurons do not, but can be induced by calmodulin activation.\",\n      \"method\": \"Whole-cell patch-clamp electrophysiology in cortical slices, pharmacological dissection (mGluR7 antagonists, kainate receptor antagonists), mouse conditional knockout\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean loss-of-function with defined synaptic phenotype, pharmacological dissection, multiple orthogonal approaches\",\n      \"pmids\": [\"30940718\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"N-glycosylation of mGluR7 at four asparagine residues is essential for its forward trafficking and surface expression; deglycosylated mGluR7 is retained in the ER and degraded via the autophagolysosomal pathway. N-glycosylation also promotes mGluR7 interaction with ELFN1, enabling proper localization and stable surface expression of mGluR7 at the presynaptic active zone.\",\n      \"method\": \"Site-directed mutagenesis of N-glycosylation sites, co-immunoprecipitation, immunofluorescence in heterologous cells and cultured neurons, pharmacological inhibition of glycosylation\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis plus multiple biochemical methods, single lab\",\n      \"pmids\": [\"32931036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The intracellular domain of ELFN1 controls membrane trafficking and postsynaptic localization, with a ~30 amino acid juxtamembranous region required for membrane targeting. ELFN1 exists as an obligate homodimer prior to membrane trafficking, with homodimerization mediated by the extracellular leucine-rich repeat (LRR) domain rather than the intracellular region. A single membrane-targeting motif in one protomer is sufficient for trafficking of the ELFN1 homodimer. ELFN2 (closest homolog) exhibits similar properties and can heterodimerize with ELFN1.\",\n      \"method\": \"Domain deletion mutagenesis, subcellular fractionation, co-immunoprecipitation, live-cell imaging, size-exclusion chromatography\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods with mutagenesis, single lab\",\n      \"pmids\": [\"39675706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CSNB-associated missense mutations in the extracellular ligand-binding domain of mGluR6 cause a Golgi bypass trafficking defect, preventing complex N-glycosylation and abolishing ELFN1 binding; these mutants are mislocalized in bipolar cells, revealing that Golgi trafficking and proper N-glycosylation of the mGluR6 extracellular domain are required for ELFN1 interaction and synaptic localization.\",\n      \"method\": \"Biochemical glycosylation assays, in vitro binding assays, immunofluorescence localization in bipolar cells, analysis of patient-derived missense mutations\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical and cell biology methods with disease mutations, single lab\",\n      \"pmids\": [\"39681475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ELFN1 is associated with extracellular matrix function: primary skin fibroblasts from patients carrying a frameshift mutation in the ELFN1 signal peptide show severely reduced ELFN1 expression and dramatically altered fibroblast morphology, growth, proliferation, and motility, suggesting ELFN1 is involved in cell-ECM attachment.\",\n      \"method\": \"Primary fibroblast culture from patient skin biopsies, in vitro ECM and decellularized ECM (DEM) models, comparative morphological and functional characterization\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, indirect loss-of-function via patient mutation, no direct molecular mechanism established\",\n      \"pmids\": [\"38986898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Biallelic ELFN1 variants (frameshift and in-frame deletions) disrupt ELFN1 protein trafficking to the cell surface, resulting in loss of function; functional modeling in mice and zebrafish demonstrates that Elfn1 loss causes motor activity abnormalities and seizures.\",\n      \"method\": \"Patient variant characterization, cell surface trafficking assays, mouse and zebrafish loss-of-function models with behavioral/seizure phenotyping\",\n      \"journal\": \"Genetics in medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — trafficking assay with multiple patient variants, in vivo model validation\",\n      \"pmids\": [\"40576023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The LRR and LRR C-terminal cap (LRRCT) regions of the ELFN1 extracellular domain are necessary and sufficient for binding to all Group III mGluRs including mGluR6. Deletion of the LRRCT domain abolishes trafficking of ELFN1 to rod photoreceptor axon terminal spherules. In mGluR6-null mice, presynaptic ELFN1 loses precise colocalization with synapses, and this defect is rescued by expressing mGluR6-EGFP in ON-bipolar cells, demonstrating bidirectional mutual regulation of presynaptic ELFN1 and postsynaptic mGluR6 enrichment.\",\n      \"method\": \"In vitro binding assays with ELFN1 domain deletion constructs, immunofluorescence in mGluR6 knockout and rescue mice, expression of ELFN1-flag domain deletion constructs in rods\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — domain mapping with binding assay plus in vivo rescue, single lab\",\n      \"pmids\": [\"40930976\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ELFN1 is a postsynaptic transmembrane cell adhesion molecule expressed in somatostatin/O-LM interneurons that acts as a transsynaptic allosteric modulator of all group III metabotropic glutamate receptors (mGluR4/6/7/8) via its extracellular LRR-LRRCT domain, constitutively activating presynaptic mGluR7 in a glutamate-independent manner to suppress initial release probability and generate facilitating synapses; it exists as an obligate homodimer whose membrane trafficking is controlled by a juxtamembranous intracellular motif, and loss of ELFN1 function in mice and humans causes seizures, hyperactivity, and neurodevelopmental encephalopathy.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ELFN1 is a postsynaptic leucine-rich repeat transmembrane protein that functions as a transsynaptic organizer of facilitating synapses by allosterically modulating presynaptic group III metabotropic glutamate receptors. Selectively expressed in somatostatin-positive interneurons, ELFN1 binds in trans to mGluR4, mGluR6, mGluR7, and mGluR8 via its extracellular LRR-LRRCT domain, constitutively activating mGluR7 in a glutamate-independent manner to suppress initial release probability and recruit GluK2-containing kainate receptors as a second facilitating component [PMID:23042292, PMID:29686062, PMID:30940718]. ELFN1 exists as an obligate homodimer mediated by its LRR domain, with membrane trafficking controlled by a juxtamembranous intracellular motif, and proper N-glycosylation of its mGluR partners is required for stable ELFN1 binding and synaptic localization [PMID:39675706, PMID:32931036, PMID:40930976]. Biallelic loss-of-function variants in ELFN1 cause a neurodevelopmental syndrome with seizures, hyperactivity, and motor abnormalities in humans and animal models [PMID:25047565, PMID:40576023].\",\n  \"teleology\": [\n    {\n      \"year\": 2012,\n      \"claim\": \"Establishing that ELFN1 is a synapse-type-specific organizer: the fundamental question of what molecular mechanism generates facilitating synapses onto O-LM interneurons was answered by showing that postsynaptic ELFN1 expression controls presynaptic release probability.\",\n      \"evidence\": \"Expression mapping combined with loss-of-function electrophysiology in hippocampal slices\",\n      \"pmids\": [\"23042292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-synaptic binding partner not yet identified\", \"Mechanism of presynaptic modulation unknown\", \"Broader expression outside O-LM interneurons unexplored\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identifying the trans-synaptic partner: the unknown presynaptic target of ELFN1 was revealed to be mGluR7, with ELFN1 recruiting mGluR7 to specific synaptic sites; human epilepsy-associated mutations in the ELFN1 C-terminal region disrupted this interaction, linking ELFN1 dysfunction to neurological disease.\",\n      \"evidence\": \"Co-immunoprecipitation, immunofluorescence, Elfn1 knockout electrophysiology, human patient mutation analysis\",\n      \"pmids\": [\"25047565\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ELFN1 interacts with other mGluR subtypes unknown\", \"Mechanism of allosteric modulation not established\", \"Whether ELFN1 acts only postsynaptically or also presynaptically unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defining the allosteric mechanism: it was unknown how ELFN1 modulates mGluR function; reconstitution showed ELFN1 binds all group III mGluRs (but not other subtypes) via two ectodomain sites and acts as a transsynaptic allosteric modulator that alters both agonist-induced and constitutive G protein coupling.\",\n      \"evidence\": \"Site-directed mutagenesis, transcellular signaling reconstitution in HEK293 cells, BRET-based G protein activation and cAMP assays\",\n      \"pmids\": [\"29686062\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of allosteric modulation unresolved\", \"In vivo relevance for mGluR4/6/8 interactions not tested\", \"Whether two binding sites have distinct functional roles unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating glutamate-independent constitutive activation: it was unclear whether ELFN1/mGluR7 signaling required glutamate; electrophysiology showed ELFN1 constitutively activates mGluR7 through presynaptic clustering, tonically suppressing release probability, and additionally recruits GluK2-KARs as a second facilitating mechanism with layer-specific differences.\",\n      \"evidence\": \"Whole-cell patch-clamp in cortical slices with pharmacological dissection and conditional knockout\",\n      \"pmids\": [\"30940718\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of GluK2-KAR recruitment by ELFN1 unknown\", \"How calmodulin regulates layer-specific differences not defined\", \"Whether ELFN2 has similar dual-receptor organizing capacity untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Establishing glycosylation dependence of the interaction: it was unknown what post-translational modifications regulate the ELFN1-mGluR7 complex; N-glycosylation of mGluR7 proved essential for both surface trafficking and ELFN1 binding.\",\n      \"evidence\": \"N-glycosylation site mutagenesis, co-immunoprecipitation, immunofluorescence in heterologous cells and neurons\",\n      \"pmids\": [\"32931036\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether ELFN1 itself requires glycosylation for function not addressed\", \"In vivo validation of glycosylation mutants lacking\", \"Stoichiometry of the glycosylated mGluR7-ELFN1 complex unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolving quaternary structure and trafficking: the oligomeric state and trafficking determinants of ELFN1 were unknown; ELFN1 was shown to be an obligate LRR-mediated homodimer, with a ~30 amino acid juxtamembranous intracellular motif controlling membrane targeting, and a single motif in one protomer sufficient for dimer trafficking.\",\n      \"evidence\": \"Domain deletion mutagenesis, size-exclusion chromatography, co-immunoprecipitation, live-cell imaging\",\n      \"pmids\": [\"39675706\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structure of the ELFN1 homodimer not determined at atomic resolution\", \"Whether homodimerization is required for mGluR binding not tested\", \"Identity of the juxtamembranous motif-binding trafficking machinery unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Mapping the minimal mGluR-binding domain and demonstrating bidirectional synaptic stabilization: the LRR-LRRCT region was shown to be necessary and sufficient for all group III mGluR binding, LRRCT deletion abolished presynaptic trafficking to rod spherules, and mGluR6 expression in postsynaptic bipolar cells was required to stabilize presynaptic ELFN1, establishing mutual transsynaptic enrichment.\",\n      \"evidence\": \"ELFN1 domain deletion binding assays, immunofluorescence in mGluR6 knockout and rescue mice, rod-specific transgene expression\",\n      \"pmids\": [\"40930976\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of LRR-LRRCT interaction with mGluR Venus flytrap domain unresolved\", \"Whether bidirectional stabilization occurs at all ELFN1-expressing synapses unknown\", \"Functional consequences of losing presynaptic ELFN1 in retina not measured electrophysiologically\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Establishing ELFN1 as a Mendelian disease gene: biallelic loss-of-function variants were shown to disrupt ELFN1 surface trafficking and cause a neurodevelopmental encephalopathy with seizures and motor abnormalities, validated across human patients and animal models.\",\n      \"evidence\": \"Patient variant characterization, cell surface trafficking assays, mouse and zebrafish loss-of-function behavioral phenotyping\",\n      \"pmids\": [\"40576023\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genotype-phenotype correlations for different variant types not established\", \"Whether heterozygous carriers have intermediate phenotypes unclear\", \"Circuit-level mechanisms linking ELFN1 loss to seizure generation not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the atomic structure of the ELFN1 homodimer-mGluR complex, the identity of intracellular trafficking machinery recognizing the juxtamembranous motif, the molecular basis of GluK2-KAR recruitment, and whether ELFN1 has non-neuronal functions related to its effects on fibroblast morphology.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of the ELFN1-mGluR transsynaptic complex exists\", \"Intracellular signaling partners and scaffolding interactions of ELFN1 C-terminal domain undefined\", \"Potential ECM/fibroblast role observed only in a single low-confidence study\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 4]},\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 2, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [6, 9]},\n      {\"term_id\": \"GO:0043226\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 2, 4]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GRM7\", \"GRM4\", \"GRM6\", \"GRM8\", \"GRIK2\", \"ELFN2\"],\n    \"other_free_text\": []\n  }\n}\n```"}